About
Paragonix Technologies, Inc. is a developer and manufacturer of advanced organ preservation technologies aimed at improving organ transplantation outcomes worldwide. Founded in 2010 and based in Waltham, Massachusetts, the company operates a 34,000-square-foot facility that supports research and development in transplant solutions. Paragonix offers a range of FDA-cleared and CE-marked organ preservation devices, including the Paragonix SherpaPak® for heart preservation, LUNGguard® for lung preservation, and LIVERguard® for liver preservation. Their products utilize stable hypothermic cooling techniques combined with digital tracking and monitoring, ensuring optimal preservation conditions throughout the donor organ journey. The company serves over 175 transplant centers globally and has supported more than 10,000 transplant cases since 2018, backed by a 24/7 support system staffed by experienced transplant clinicians. Recognized for its innovation, Paragonix is committed to enhancing patient outcomes and the safety of donated organs, setting new standards in the field of organ transplantation.
Technologies
Keywords
Company Information
-
Employees 160
-
Founded 2010
-
Annual Revenue $43100000
-
Total Funding $24778459
Location
950 Winter St, Waltham, Massachusetts, United States, 02451-1404